Calendar Editor, Health & Maturity Editor, Vox
Julia Belluz is a health journalist and the Calendar Editor and Health & Maturity Editor at Vox. With a focus on nutrition, metabolism, and obesity, Julia's work explores the intersection of science, health, and policy. Her articles have been featured in publications such as Vox, STAT, and The New York Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Julia Belluz's coverage focuses on health and pharmaceutical topics, particularly with an emphasis on legal policy regulation and data citations. Based on this, she may be interested in receiving pitches from experts who can provide in-depth analysis of healthcare policies or medical research findings.
Given her focus on citing data and regulations, sources with access to the latest studies or expertise in public health policy could capture her attention. Additionally, individuals knowledgeable about regulatory aspects of pharmaceuticals or healthcare systems may find success when reaching out to Julia.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Drugs like Ozempic and Wegovy are changing how patients view their own weight struggles. Will society follow?
By: Julia Belluz, Laura Chang
The enormous cost estimates of obesity in a new report may even be an underestimate, researchers told STAT.
Semaglutide users, and even researchers, have to dig to learn about risks. Why is this information so hard to find?
The drugs are linked to birth defects in animal studies. Why information on this side effect so hard to find?
Semaglutide — which Novo Nordisk calls Wegovy — is the start of a new chapter in obesity treatment. It was inspired by a lizard’s venom.
Covid-19 only intensified the long hours and stressful work environment of America’s doctors. But as the pandemic took a toll on their mental health, their own profession failed some who reached out for help.
The agency paid the consultants a total of $11.7 million — enough to buy around 600,000 Covid-19 vaccines.
(833) 317-6278 
